ARTICLE | Clinical News
Lentiviral gene delivery system regulatory update
February 14, 2000 8:00 AM UTC
The Salk Institute (San Diego, Calif.) received U.S. Patent No. 6,013,516 covering lentiviral gene delivery systems of human and non-human origin. CEGE, which is the exclusive worldwide licensee of th...